Astro-Med, Inc. 10-Q Summary
Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for Astro-Med, Inc., covering the three-month and nine-month periods ended November 2, 2002. The company operates in three reporting segments: Test & Measurement (T&M), QuickLabel Systems (QLS), and Grass-Telefactor (G-T). The filing includes unaudited consolidated financial statements and management's discussion and analysis.
Key Financial Metrics
| Metric | Three Months Ended Nov 2, 2002 | Nine Months Ended Nov 2, 2002 |
|---|---|---|
| Net Sales | $11,747,008 | $36,051,280 |
| Gross Profit | $4,389,822 (37.4% margin) | $13,053,938 (36.2% margin) |
| Operating Loss | $(502,252) | $(1,401,853) |
| Net Loss | $(310,629) | $(787,161) |
| Loss Per Share (Basic/Diluted) | $(0.07) | $(0.18) |
| Cash Flow from Operations | N/A | $2,071,498 |
| Cash and Equivalents (End of Period) | $3,310,952 | $3,310,952 |
| Total Debt (Current + Long-Term) | $1,488,089 | $1,488,089 |
Liquidity: Total current assets were $26,523,010 against current liabilities of $5,628,588. The company maintains a strong cash position with $3.31 million in cash and $3.73 million in securities available for sale.
Material Changes vs. Prior Period
- Revenue: Three-month sales decreased 5% to $11.75 million compared to $12.40 million in the prior year. Nine-month sales decreased 2% to $36.05 million from $36.97 million.
- Profitability: Net loss widened significantly. The nine-month net loss increased to $787,000 from $274,000 in the prior year. Operating loss for the nine months increased to $1.40 million from $728,000.
- Segment Performance:
- T&M: Sales were flat to slightly down; segment profit margin improved to 13% (quarter) and 7% (nine months) due to strong Dash 18 recorder demand.
- QLS: Sales declined 11% in the quarter and increased 4% over nine months. The segment moved from profit to loss in the quarter due to a 43% drop in Printer System sales.
- G-T: Sales increased 1% in the quarter but declined 12% over nine months. Operating loss margin improved in the quarter but profit margin declined over nine months.
- Expenses: Selling, General, and Administrative (SG&A) expenses declined 4% in the quarter and 7% over nine months due to workforce reductions. Research and Development (R&D) spending increased 18% in the quarter and 11% over nine months, driven by new product development.
- Cash Flow: Net cash provided by operating activities improved dramatically to $2.07 million for the nine months, compared to only $143,000 in the prior year, driven by reductions in accounts receivable and inventory.
Guidance, Outlook, and Risks
Management Commentary: Management attributes the decline in international sales to weakness in Western European markets and lower shipments to Asia and Central America. The company notes improved inventory control (turns improved to 2.6 times) and accounts receivable collection (56 days outstanding).
Risks and Contingencies:
- General economic conditions and declining demand in defense and aerospace markets.
- Competition in specialty printer, data acquisition, and neurophysiology industries.
- Ability to develop market acceptance for QLS color printer products.
- Impact of foreign currency exchange rate changes.
Dividends: The company declared dividends of $0.04 per share for the quarter and $0.12 per share for the nine-month period.
Investor Verification Checklist
- Segment Mix Shift: Verify the sustainability of the margin improvement in T&M versus the margin erosion in QLS and G-T.
- International Exposure: Assess the impact of continued weakness in European and Asian markets on future revenue.
- R&D ROI: Monitor the return on the increased R&D spending (up 11-18%) regarding new T&M product launches.
- Working Capital Management: Confirm if the significant improvement in cash flow from operations (driven by lower receivables and inventory) is a one-time benefit or a sustained trend.
- Debt Levels: Note the low total debt ($1.49M) relative to cash and securities ($7.04M), indicating a conservative capital structure.